Biotech Investment Analyst

🕒 August 8

🗽 New York – Remote

🗽 New York – Remote

💵 $125 - $185 / hour

⏳ Contract/Temporary

🟡 Mid-level

🟠 Senior

💸 Financial Planning and Analysis (FP&A)

👻 Ghost score 4%

What it means: how likely this posting is sitting open without active hiring.How to read it: 60% or higher means we think this is a ghost. Lower scores are less of a worry.How we score it: age, reposts, open roles vs team size, how fast jobs close, and whether pay is listed.Fine print: an estimate from public data, not a judgment of the company. Real jobs can score high, so treat it as a hint, not a fact.

Apply Now

Find Similar Remote Jobs

Set Up Email Alert For New Jobs

📊 Check your resume score for this job

Improve your chances of getting an interview by checking your resume score before you apply.

Upload Resume

24-MAG

WebsiteLinkedInAll Job Openings

2 - 10 employees

🤝 B2B

💼 Consulting

B2B • Consulting

24-MAG is a commercial strategy and execution firm that helps B2B organizations design and implement systems, workflows, and operating rhythms for sales, client management, and cross-functional projects. They focus on transforming scattered processes into aligned, measurable, and scalable commercial functions—covering pipeline structure, account management frameworks, and operational discipline for teams seeking efficient, intentional growth.

📋 Description

• Evaluate commercial and clinical-stage drug assets across different therapeutic areas • Assess mechanism of action, biological rationale, clinical data, development progress, and regulatory considerations • Analyse competitive positioning within relevant therapeutic and treatment landscapes • Identify scientific, clinical, regulatory, and commercial value drivers • Flag unsupported assumptions, evidence gaps, or material risks within asset assessments • Conduct end-to-end assessments of biotech and pharmaceutical companies • Evaluate pipeline quality, company strategy, competitive differentiation, and major catalysts • Assess the relationship between individual drug assets and overall company valuation • Review investment-style theses for analytical strength, supporting evidence, and internal consistency • Apply consistent investment judgement across approximately 5–10 companies during the pilot • Interpret clinical trial results and assess the strength and relevance of available evidence • Evaluate potential differentiation against existing and emerging standards of care • Analyse addressable markets, competitive dynamics, development timelines, and commercial opportunity • Assess how clinical, regulatory, and market developments may affect asset and company value • Distinguish between well-supported conclusions and speculative investment assumptions • Create structured evaluation rubrics for biotech companies and drug-development programmes • Critique existing rubrics for completeness, realism, and investment relevance • Define criteria reflecting experienced biotech investment judgement • Identify missing considerations or weak assumptions in analytical frameworks • Provide clear written reasoning supporting evaluation decisions

🎯 Requirements

• 5+ years of experience evaluating biotech, pharmaceutical, or healthcare companies or assets • Professional experience as a biotech or healthcare investment analyst, ideally within a specialist investment fund • Strong familiarity with biotech and pharmaceutical drug-development programmes • Experience assessing drug assets from scientific, clinical, commercial, and investment perspectives • Strong understanding of clinical data, mechanisms of action, competitive landscapes, and biotech valuation drivers • Ability to evaluate both individual assets and the broader companies developing them • Experience developing, reviewing, or presenting investment theses • Strong analytical judgement and ability to identify unsupported or incomplete assumptions • US-based or possessing deep professional experience covering the US biotech and healthcare investment market • Availability for approximately 10–20 hours over an initial 1–2 week pilot • Part-time independent contractor engagement • Work must be completed without using confidential or proprietary information belonging to any employer, client, fund, institution, or other third party • H1-B and STEM OPT support is unavailable for this engagement

🏖️ Benefits

• Fully remote with flexible scheduling • Compensation of $125–$185/hour • Potential for recurring project work for strong contributors